Schizophrenia: all 3,539 studies

Page 7 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of SchizophreniaTerminatedNCT03648268Not applicableResults posted
• A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive DisorderTerminatedNCT03643159Phase 4Results posted
• Adapting Critical Time Intervention to Support Inpatient Medical Care TransitionTerminatedNCT03637296Not applicableResults posted
• A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaCompletedNCT03627195Phase 1Results posted
• Prebiotic Treatment in People With Schizophrenia - Pilot StudyCompletedNCT03617783Phase 4Results posted
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With SchizophreniaTerminatedNCT03593213Phase 3Results posted
• tDCS and Cognitive Training Intervention for Chronic Smokers With SchizophreniaTerminatedNCT03588728Not applicableResults posted
• Improving Accessibility and Personalization of CR for SchizophreniaCompletedNCT03576976Not applicableResults posted
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
• A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)CompletedNCT03565068Phase 1Results posted
• A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationCompletedNCT03557931Phase 2Results posted
• Boost rTMS for Auditory Verbal HallucinationsTerminatedNCT03544333Not applicableResults posted
• Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use DisorderCompletedNCT03526354Phase 4Results posted
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1TerminatedNCT03507127Phase 2Results posted
• Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCompletedNCT03503318Phase 3Results posted
• Individualizing Incentives for Alcohol in the Severely Mentally IllCompletedNCT03481049Not applicableResults posted
• Integrated Care (IC) Models for Patient-Centered OutcomesCompletedNCT03451630Not applicableResults posted
• Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With SchizophreniaTerminatedNCT03437668Phase 2/3Results posted
• Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)CompletedNCT03427580Not applicableResults posted
• Motivation and Skills Support (MASS)CompletedNCT03404219Not applicableResults posted
• Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaCompletedNCT03397134Phase 3Results posted
• A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of SchizophreniaCompletedNCT03382639Phase 2Results posted
• Stimulating the Brain to Improve Self-AwarenessCompletedNCT03370341Not applicableResults posted
• Bridge: Proactive Psychiatry Consultation and Case Management for Patients With CancerCompletedNCT03360695Not applicableResults posted
• A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With SchizophreniaCompletedNCT03359785Phase 2Results posted
• This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 MonthsTerminatedNCT03351244Phase 2Results posted
• A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of SchizophreniaCompletedNCT03345979Phase 3Results posted
• A Study of Paliperidone Palmitate 6-Month FormulationCompletedNCT03345342Phase 3Results posted
• Brain Stimulation and Cognitive TrainingCompletedNCT03338673Not applicableResults posted
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaCompletedNCT03323437Phase 4Results posted
• Glutamate Reducing Interventions in SchizophreniaCompletedNCT03321617Phase 1Results posted
• A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable SchizophreniaCompletedNCT03319953Phase 2Results posted
• Theta Burst Stimulation for SchizophreniaCompletedNCT03288779Not applicableResults posted
• Circuitry-Guided Smoking Cessation in SchizophreniaCompletedNCT03281629Not applicableResults posted
• Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric DisordersCompletedNCT03275766Not applicableResults posted
• Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With SchizophreniaCompletedNCT03238326Phase 3Results posted
• Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaTerminatedNCT03230864Phase 3Results posted
• Targeting Auditory Hallucinations With Alternating Current StimulationCompletedNCT03221270Not applicableResults posted
• TMS Enhancement of Visual Plasticity in SchizophreniaTerminatedNCT03220438Not applicableResults posted
• Restoration of Cognitive Function With TDCS and Training in Serious Mental IllnessCompletedNCT03208036Not applicableResults posted
• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831CompletedNCT03201757Phase 3Results posted
• Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With SchizophreniaCompletedNCT03198078Phase 3Results posted
• Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderCompletedNCT03187769Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute SchizophreniaCompletedNCT03160521Phase 3Results posted
• Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in SchizophreniaTerminatedNCT03132571Phase 2Results posted
• Levetiracetam in Early PsychosisCompletedNCT03129360Phase 2Results posted
• Virtual Reality Training for Social Skills in SchizophreniaCompletedNCT03128099Not applicableResults posted
• Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaTerminatedNCT03121586Phase 3Results posted
• Modulating Human Cortical Plasticity With Transcranial Electrical StimulationCompletedNCT03114488Not applicableResults posted
• Minnesota Community-Based Cognitive Training in Early PsychosisCompletedNCT03079024Not applicableResults posted
• The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in SchizophreniaTerminatedNCT03077347Not applicableResults posted
• Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness TherapyCompletedNCT03067311Not applicableResults posted
• Effectiveness of a Mobile Texting Intervention for People With Serious Mental IllnessCompletedNCT03062267Not applicableResults posted
• An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)CompletedNCT03055338Phase 2Results posted
• Virtual Reality Job Interview Training in Severe Mental IllnessCompletedNCT03049813Not applicableResults posted
• Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic StimulationCompletedNCT03037983Not applicableResults posted
• Reducing Hippocampal Hyperactivity and Improving Cognition in SchizophreniaCompletedNCT03034356Phase 1/2Results posted
• Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose ReductionCompletedNCT03019887Not applicableResults posted
• PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 MutationsTerminatedNCT02983058Not applicableResults posted
• Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in SchizophreniaCompletedNCT02975973Not applicableResults posted
• An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With SchizophreniaCompletedNCT02970929Phase 2Results posted
• Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)CompletedNCT02970305Phase 2Results posted
• Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)CompletedNCT02970292Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With SchizophreniaCompletedNCT02969382Phase 2Results posted
• Minocycline and Tobacco Craving in Smokers With SchizophreniaCompletedNCT02968602Phase 4Results posted
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With AntipsychoticsCompletedNCT02953639Phase 2Results posted
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine HydrochlorideCompletedNCT02943213Phase 1Results posted
• Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic DisordersCompletedNCT02930005Phase 2Results posted
• E-cigarettes to Promote Smoking Reduction Among Individuals With SchizophreniaCompletedNCT02918630Not applicableResults posted
• Brief Group Psychoeducation for SchizophreniaCompletedNCT02911519Not applicableResults posted
• Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With SchizophreniaCompletedNCT02892422Phase 3Results posted
• Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.CompletedNCT02876900Phase 3Results posted
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02873208Phase 3Results posted
• Remediation of Auditory Recognition in Schizophrenia With tDCSCompletedNCT02869334Not applicableResults posted
• A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)TerminatedNCT02855411Phase 2Results posted
• Integrated Smoking Cessation Treatment for Smokers With Serious Mental IllnessCompletedNCT02845440Not applicableResults posted
• Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in SchizophreniaCompletedNCT02832037Phase 2Results posted
• Lifestyle Intervention for Young Adults With Serious Mental IllnessCompletedNCT02815813Not applicableResults posted
• Sulforaphane to Reduce Symptoms of SchizophreniaCompletedNCT02810964Phase 2Results posted
• MEtformin and Lorcaserin for WeighT Loss in SchizophreniaTerminatedNCT02796144Phase 4Results posted
• Comparative Effectiveness of Adaptive Treatment Strategies for SchizophreniaCompletedNCT02775864Results posted
• Safety and Tolerability of Risperidone ImplantsCompletedNCT02773576Phase 3Results posted
• Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS)TerminatedNCT02764164Not applicableResults posted
• Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics StudyCompletedNCT02748694Phase 1Results posted
• Non-Invasive Direct Current Stimulation for Cognition in SchizophreniaTerminatedNCT02739347Not applicableResults posted
• Naltrexone and Bupropion Combination on Obese,Smoking Patients With SchizophreniaCompletedNCT02736474Phase 4Results posted
• Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine SystemCompletedNCT02722967Phase 2Results posted
• Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaCompletedNCT02717195Phase 3Results posted
• Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02717130Not applicableResults posted
• Benefits of Physical Exercise in SchizophreniaCompletedNCT02716584Not applicableResults posted
• The Use of Transcranial Electrical Stimulation for HallucinationsTerminatedNCT02715765Not applicableResults posted
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)CompletedNCT02694328Phase 3Results posted
• Aspirin in Young Psychotic PatientsCompletedNCT02685748Phase 2/3Results posted
• Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended TreatmentCompletedNCT02676375Phase 4Results posted
• A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02669758Phase 3Results posted
• Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental IllnessCompletedNCT02663349Not applicableResults posted
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT02658357Phase 2Results posted
• Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in SchizophreniaCompletedNCT02647437Not applicableResults posted
• Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) StudyCompletedNCT02642029Not applicableResults posted
• Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.CompletedNCT02634684Phase 2Results posted

← Schizophrenia overview